Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review
Maintenance of remission during pregnancy is vital for women with inflammatory bowel disease (IBD). The antenatal safety of novel small molecules for IBD is yet to be ascertained. We aimed to describe the current evidence on reproductive data regarding small-molecule drugs. We performed a systematic...
Main Authors: | Niloufar Monfared, Matthew Gold, Isabel Carbery, Robyn Laube, Christian P. Selinger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/1/34 |
Similar Items
-
Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Badr Al-Bawardy, et al.
Published: (2021-04-01) -
Small Molecule Drugs in Inflammatory Bowel Diseases
by: Inès Ben Ghezala, et al.
Published: (2021-06-01) -
Dual biological therapy and small molecules in pediatric inflammatory bowel disease
by: Francesca Penagini, et al.
Published: (2023-10-01) -
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
by: Jin-Woo Kim, et al.
Published: (2021-10-01) -
Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
by: Soo-Young Na, et al.
Published: (2022-09-01)